Compile Data Set for Download or QSAR
Report error Found 134 Enz. Inhib. hit(s) with all data for entry = 7191
TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180212(US9133157, 94)
Affinity DataIC50: 0.0900nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM60623(BDBM180165 | US9133157, 103)
Affinity DataIC50: 0.0900nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180171(US9133157, 53)
Affinity DataIC50: 0.156nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180183(US9133157, 65)
Affinity DataIC50: 0.180nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180163(US9133157, 44)
Affinity DataIC50: 0.196nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180201(US9133157, 83)
Affinity DataIC50: 0.300nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180164(US9133157, 45 | US9133157, 102)
Affinity DataIC50: 0.308nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180211(US9133157, 93)
Affinity DataIC50: 0.310nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180119(US9133157, 8)
Affinity DataIC50: 0.310nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180203(US9133157, 85)
Affinity DataIC50: 0.330nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180206(US9133157, 88)
Affinity DataIC50: 0.330nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180204(US9133157, 86)
Affinity DataIC50: 0.340nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180135(US9133157, 16)
Affinity DataIC50: 0.440nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180216(US9133157, 98)
Affinity DataIC50: 0.440nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180192(US9133157, 74)
Affinity DataIC50: 0.450nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180232(US9133157, 117)
Affinity DataIC50: 0.470nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180116(US9133157, 5)
Affinity DataIC50: 0.540nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180164(US9133157, 45 | US9133157, 102)
Affinity DataIC50: 0.630nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180120(US9133157, 9)
Affinity DataIC50: 0.630nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180202(US9133157, 84)
Affinity DataIC50: 0.75nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180229(US9133157, 114)
Affinity DataIC50: 0.770nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180219(US9133157, 101)
Affinity DataIC50: 0.840nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180222(US9133157, 104)
Affinity DataIC50: 0.850nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180218(US9133157, 100)
Affinity DataIC50: 0.900nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180215(US9133157, 97)
Affinity DataIC50: 1.23nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180175(US9133157, 57)
Affinity DataIC50: 1.32nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180147(US9133157, 28)
Affinity DataIC50: 1.45nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180130(US9133157, 11)
Affinity DataIC50: 1.61nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180223(US9133157, 105)
Affinity DataIC50: 1.77nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180214(US9133157, 96)
Affinity DataIC50: 1.95nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180170(US9133157, 52)
Affinity DataIC50: 2nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180178(US9133157, 60)
Affinity DataIC50: 2.01nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180191(US9133157, 73)
Affinity DataIC50: 2.03nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180151(US9133157, 32)
Affinity DataIC50: 2.27nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180136(US9133157, 17)
Affinity DataIC50: 2.40nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180233(US9133157, 118)
Affinity DataIC50: 2.43nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180207(US9133157, 89)
Affinity DataIC50: 2.60nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180121(US9133157, 10)
Affinity DataIC50: 2.60nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180176(US9133157, 58)
Affinity DataIC50: 2.71nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180209(US9133157, 91)
Affinity DataIC50: 2.90nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180235(US9133157, 120)
Affinity DataIC50: 3nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180188(US9133157, 70)
Affinity DataIC50: 3.16nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180217(US9133157, 99 | US9133157, 122)
Affinity DataIC50: 3.39nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180118(US9133157, 7)
Affinity DataIC50: 3.5nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180231(US9133157, 116)
Affinity DataIC50: 3.54nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180236(US9133157, 121)
Affinity DataIC50: 3.59nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180150(US9133157, 31)
Affinity DataIC50: 3.62nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180155(US9133157, 36)
Affinity DataIC50: 3.65nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180132(US9133157, 13)
Affinity DataIC50: 3.90nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

TargetGag-Pol polyprotein(HIV-1)
Merck Canada

US Patent
LigandPNGBDBM180167(US9133157, 49)
Affinity DataIC50: 3.96nMpH: 5.5 T: 2°CAssay Description:The inhibition of WT HIV-1 protease was studied using the reaction of the protease (expressed in Eschericia coli) with a peptide substrate [Val-Ser-G...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/16/2016
Entry Details
US Patent

Displayed 1 to 50 (of 134 total ) | Next | Last >>
Jump to: